Effects of gelucire content on stability, macrophage interaction and blood circulation of nanoparticles engineered from nanoemulsions

Colloids and Surfaces B: Biointerfaces

Volumn 94, Issue , 2012, Pages 259-265

  Wehrung, Daniel ^a   Geldenhuys, Werner J ^a   Oyewumi, Moses O ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Cetyl alcohol; Colloidal stability; Macrophages; Nanoemulsions; P gp efflux; Phagocytosis

Indexed keywords

CETYL ALCOHOL; COLLOIDAL STABILITY; NANO-EMULSIONS; P-GP EFFLUX; PHAGOCYTOSIS;

ANTIGEN-ANTIBODY REACTIONS; BINARY MIXTURES; CARDIOVASCULAR SYSTEM; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY; NANOPARTICLES;

MACROPHAGES;

CETYL ALCOHOL GELUCIRE NANOPARTICLE; GELUCIRE; GLYCOPROTEIN P; HEXADECANOL; MACROGOL 2000; NANOCARRIER; PACLITAXEL; POLYSORBATE 80; REACTIVE OXYGEN METABOLITE; RHODAMINE 123; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG RETENTION; DRUG STABILITY; EXCIPIENT COMPATIBILITY; HUMAN; HUMAN CELL; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MACROPHAGE ACTIVATION; MOUSE; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; SARCOMA CELL; SURFACE PROPERTY;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG CARRIERS; DRUG STABILITY; EMULSIONS; FATTY ALCOHOLS; HUMANS; MACROPHAGES; MICE; MICE, INBRED BALB C; NANOPARTICLES; OILS; P-GLYCOPROTEIN; PACLITAXEL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; REACTIVE OXYGEN SPECIES; RHODAMINE 123; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; WATER;

MUS;

EID: 84859157250     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.02.005     Document Type: Article

References (25)

1. Allen T.M., Cullis P.R. Science 2004, 303:1818-1822.
2. Oyewumi M.O., Yokel R.A., Jay M., Coakley T., Mumper R.J. J. Control. Release 2004, 95:613.
3. Lee S.H., Zhang Z., Feng S.S. Biomaterials 2007, 28:2041.
4. Vonarbourg A., Passirani C., Saulnier P., Benoit J.P. Biomaterials 2006, 27:4356.
5. Oyewumi M.O., Kumar A., Cui Z. Expert Rev. Vaccines 2010, 9:1095-1107.
6. Kuo J.S., Lin Y., Tseng J. Colloids Surf. B 2008, 64:208-215.
7. Iles K.E., Forman H.J. Immunol. Res. 2002, 26:95-105.
8. Dong X., Mattingly C.A., Tseng M.T., Cho M.J., Liu Y., Adams V.R., Mumper R.J. Cancer Res. 2009, 9:3918-3926.
9. Sachs-Barrable K., Thamboo A., Lee S.D., Wassan K.M. J. Pharm. Pharm. Sci. 2007, 10:319-331.
10. Traunecker H.C.L., Stevens M.C.G., Kerr D.J., Ferry D.R. Br. J. Cancer 1999, 6:942-951.
11. Noriega-Pelaez E., Mendoza-Munnoz N., Ganem-Quintanar A., Quintanar-Guerrero D. Drug Dev. Ind. Pharm. 2011, 37:160-166.
12. Xiang L., Nie S., Kong J., Li N., Ju C., Pan W. Int. J. Pharm. 2008, 363:177-182.
13. Wehrung D., Oyewumi M.O. J. Biomed. Nanotechnol. 2012, 8:161-171.
14. Oyewumi M.O., Mumper R.J. Bioconjug. Chem. 2002, 13:328-1335.
15. D. Wehrung, W.J., Geldenhuys, L. Bi, M.O. Oyewumi, J. Nanosci. Nanotechnol., in press.
16. Buyukavci M., Ozdemir O., Buck S., Stout M., Ravindranath Y., Savasan S. Fundam. Clin. Pharmacol. 2006, 20:73-79.
17. Shan X., Liu C., Yuan Y., Xu F., Tao X., Shen Y., Zhou H. Colloids Surf. B 2009, 72:303-311.
18. Zhao J., Liu C.S., Yuan Y., Tao X.Y., Shan X.Q., Sheng Y., Wu F. Biomaterials 2007, 28:1414.
19. Xu Z., Chen L., Gu W., Gao Y., Lin L., Zhang Z., Xi Y., Li Y. Biomaterials 2009, 30:226-232.
20. Koziara J.M., Oh J.J., Akers W.S., Ferraris S.P., Mumper R.J. Pharm. Res. 2005, 22:1821-1828.
21. Cornaire G., Woodley J., Hermann P., Cloarec A., Arellano C., Houin G. Int. J. Pharm. 2004, 278:119-213.
22. Goncalves C., Torrado E., Martins T., Pereira P., Pedrosa J., Gama M. Colloids Surf. B 2010, 75:483-489.
23. Fang C., Shi B., Pei Y., Hong M., Wu J., Chen H. Eur. J. Pharm. Sci. 2006, 27:27.
24. Ebrahimnejad P., Dinarvand R., Jafari M.R., Abolghasem S., Tabasi S., Atyabi F. Int. J. Pharm. 2011, 406:122-127.
25. Date A.A., Vador N., Jagtap A., Nagarsenker M.S. Nanotechnology 2011, 22:275102.